0000898432-20-000871.txt : 20201209
0000898432-20-000871.hdr.sgml : 20201209
20201209215952
ACCESSION NUMBER: 0000898432-20-000871
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201207
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scott Christopher K.
CENTRAL INDEX KEY: 0001613803
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36534
FILM NUMBER: 201379312
MAIL ADDRESS:
STREET 1: C/O IRADIMED CORPORATION
STREET 2: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRADIMED CORP
CENTRAL INDEX KEY: 0001325618
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 731408526
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
BUSINESS PHONE: 4076778022
MAIL ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
4
1
form4.xml
X0306
4
2020-12-07
0001325618
IRADIMED CORP
IRMD
0001613803
Scott Christopher K.
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS
FL
32708
true
CFO & Secretary
Common Stock
2020-12-07
4
M
0
1575
A
24840
D
Common Stock
2019-12-07
4
F
0
384
24.54
D
24456
D
Common Stock
2020-12-07
4
M
0
2731
A
27187
D
Common Stock
2019-12-07
4
F
0
665
24.54
D
26522
D
Restricted Stock Units
2020-12-07
4
A
0
5094
0
A
Common Stock
5094
5094
D
Performance-Based Restricted Stock Units
2020-12-07
4
A
0
5093
0
A
Common Stock
5093
5093
D
Restricted Stock Units
2020-12-07
4
M
0
1575
0
D
Common Stock
1575
3150
D
Restricted Stock Units
2020-12-07
4
M
0
2731
0
D
Common Stock
2731
8195
D
Restricted stock units convert into common stock on a one-for-one basis.
Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2020 through December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested.
On December 7, 2018, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
/s/ Christopher K. Scott
2020-12-09